Description
Here are some of the uses of ASOMEX 2.5mg:
- Treatment of hypertension
- Treatment of angina
- Management of Raynaud’s phenomenon
- Prevention of migraine headaches
Sh9,000.00
ASOMEX 2.5mg is a medication that contains amlodipine besylate, which belongs to the class of calcium channel blockers. It is used to treat high blood pressure (hypertension) and certain types of angina (chest pain).
Here are some of the uses of ASOMEX 2.5mg:
| Settings | ASOMEX 2.5MG remove | Ampiclox Syrup remove | AMBROSAN SYRUP AMBROXOL 100ML remove | Artequick Tablets remove | Artemether Syrup 60ml ARH-L remove | AMBRODIL DROPS 15ML remove |
|---|---|---|---|---|---|---|
| Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| SKU | ||||||
| Rating | ||||||
| Price | Sh9,000.00 | Sh2,500.00 | Sh3,000.00 | Sh11,000.00 | Sh4,000.00 | Sh2,500.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description | ASOMEX 2.5mg is a medication that contains amlodipine besylate, which belongs to the class of calcium channel blockers. It is used to treat high blood pressure (hypertension) and certain types of angina (chest pain). | |||||
| Content | Here are some of the uses of ASOMEX 2.5mg:
| It is a powder containing Ampicillin trihydrate B.P. and Cloxacillin. When dispensed as directed each 5 ml of the suspension contains the equivalent of 125 mg Ampicillin and 125 mg Cloxacillin. It is used to treat Infections caused by susceptible organisms where a mixed infection is present and includes penicillin-resistant staphylococci. | Prescribed for various respiratory diseases such as
| Artequick Tablet Is Used For The Treatment, Control, Prevention, & Improvement Of Malaria And; Acute Liver Injury | Artemether(Coartem) generic Artemether is a potent and quick-acting antimalarial agent, used for treating chloroquine-resistant falciparum malaria, including cerebral malaria. | It is used to treat
|
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.